April 24, 2026 08:00 ET | Source: Aligos Therapeutics SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos…
Revenue as at 31 March 2026 stood at €1,336m, up +4.9% on an organic basis compared with the first quarter…
Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including…
April 23, 2026 12:00 ET | Source: Catheter Precision, Inc. VIVO System to be featured in educational sessions at HRS…
Kenneth Tripp, Dr. Sachin Shridharani, and E. Scott Beattie bring deep expertise in medical devices, aesthetic medicine, and global consumer…
Pairing Decontamination Versatility with Domestic Lithium Power to Meet the Global Demand for High-Performance Automated Disinfection April 22, 2026 16:05…
Abivax to Present Data on Obefazimod at Digestive Disease Week® Presentations Highlight Comprehensive Efficacy, Safety, and Patient-Reported Outcomes from the…
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…
Des Moines, IA, April 21, 2026 (GLOBE NEWSWIRE) -- The information below contains affiliate links. If a purchase is made…
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…